Advisory Services Network, LLC Innoviva, Inc. Transaction History

Advisory Services Network, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$11.8 - $13.78 $129 - $151	11 New	11 $0
Q1 2021 May 24, 2021	SELL	$11.06 - $12.87 $519 - $604	-47 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$9.33 - $12.48 $401 - $536	43 Added 1075.0%	47 $1,000
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $41 - $57	4 New	4 $0
Q2 2020 Aug 10, 2020	SELL	$11.49 - $15.26 $45 - $61	-4 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $32 - $60	4 New	4 $0
Q1 2019 May 20, 2019	SELL	$13.69 - $20.06 $194,261 - $284,651	-14,190 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$13.96 - $18.26 $198,092 - $259,109	14,190 New	14,190 $248,000
Q2 2018 Jul 27, 2018	SELL	$13.44 - $17.59 $9,354 - $12,242	-696 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	696	696 $9,000

226

78.8M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.29B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.